|
SBK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.485160E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.322250E-01 |
| Normal-vs-Stage2 |
1.371680E-02 |
| Normal-vs-Stage3 |
9.492200E-01 |
| Normal-vs-Stage4 |
4.976800E-01 |
| Stage1-vs-Stage2 |
5.767600E-02 |
| Stage1-vs-Stage3 |
2.317000E-01 |
| Stage1-vs-Stage4 |
9.741900E-02 |
| Stage2-vs-Stage3 |
1.814340E-02 |
| Stage2-vs-Stage4 |
9.475600E-03 |
| Stage3-vs-Stage4 |
5.880800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.889000E-01 |
| Normal-vs-AfricanAmerican |
3.393000E-01 |
| Normal-vs-Asian |
8.373400E-01 |
| Caucasian-vs-AfricanAmerican |
4.627000E-01 |
| Caucasian-vs-Asian |
5.516000E-01 |
| AfricanAmerican-vs-Asian |
3.766600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.780160E-01 |
| Normal-vs-Female |
2.313600E-01 |
| Male-vs-Female |
6.526600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.520000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.801600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.382410E-01 |
| Normal-vs-Age(81-100Yrs) |
8.255600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.843800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.665400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.786000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.607200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.807800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.060400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.80729999965656E-07 |
| Classical-VS-Follicular |
5.458100E-02 |
| Classical-VS-Other |
4.938200E-01 |
| Classical-VS-Normal |
2.149600E-01 |
| Tall-VS-Follicular |
1.52470000003291E-06 |
| Tall-VS-Other |
1.555600E-01 |
| Tall-VS-Normal |
1.400820E-04 |
| Follicular-VS-Other |
8.857800E-01 |
| Follicular-VS-Normal |
1.274310E-02 |
| Other-VS-Normal |
4.943600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.557600E-03 |
| Normal-vs-N1 |
9.675800E-01 |
| N0-vs-N1 |
4.571600E-02 |
|
|
